Calcium carbonate 250 MG/ML Oral Suspension — RxCUI 308891
RxNorm drug concept · Semantic clinical drug
RxCUI 308891
Semantic clinical drug · SCD
● Current RxNorm concept 3 FDA products
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI308891
Official nameCalcium carbonate 250 MG/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known ascalcium carbonate 1250 MG (calcium 500 MG) per 5 ML Oral Suspension; calcium carbonate 1250 MG in 5 mL Oral Suspension
FDA products mapped3
Package NDCs mapped3
Reported Medicaid activity (SDUD)26,485 prescriptions · 34 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Calcium Carbonate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Most people use it as a fast-acting antacid to get quick relief from heartburn, acid indigestion, sour stomach, or an upset stomach. You'll find it in brands like Tums, Rolaids, an...
- What is calcium carbonate actually used for?
- Don't use the maximum daily dose for more than 2 weeks in a row without talking to a doctor first. If your heartburn or stomach symptoms keep coming back or don't improve, that's y...
- How long can I keep taking this before I should see a doctor?
🕸️ Concept Web — How Calcium carbonate 250 MG/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Calcium carbonate 250 MG/ML Oral Suspension
RxCUI 308891 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Calcium carbonate
1897IN
-
Calcium carbonate
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Calcium carbonate Oral Suspension
371200SCDF -
Calcium carbonate Oral Liquid Product
1154143SCDG -
Calcium carbonate Oral Product
1154144SCDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG -
Oral Product
1151131DFG
-
Calcium carbonate Oral Suspension
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Calcium carbonate 250 MG/ML
329213SCDC
-
Calcium carbonate 250 MG/ML
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Calcium carbonate 250 MG/ML
SCDC · 329213 -
Calcium carbonate Oral Suspension
SCDF · 371200 -
Calcium carbonate Oral Liquid Product
SCDG · 1154143 -
Calcium carbonate Oral Product
SCDG · 1154144
📦 FDA Products & Package NDCs
3 products · 3 package NDCs
3 package NDCs map to RxCUI 308891 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00121-0766-16 | 12 BOTTLE in 1 CASE (0121-0766-16) / 473 mL in 1 BOTTLE | Calcium Carbonate | PAI Holdings, LLC dba PAI Pharma | 2004-12-01 |
| 00121-4766-05 | 4 TRAY in 1 CASE (0121-4766-05) / 10 CUP, UNIT-DOSE in 1 TR... | Calcium Carbonate | PAI Holdings, LLC dba PAI Pharma | 2004-12-01 |
| 17856-3117-03 | 5 mL in 1 CUP (17856-3117-3) | Calcium Carbonate | Atlantic Biologicals Corps | 2021-01-28 |
Observed labelers:
PAI Holdings, LLC dba PAI Pharma (2) ·
Atlantic Biologicals Corps (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.0204
Range $0.0204–$0.0204
· middle 50% $0.0204–$0.0204
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.